Insider Shareholders with Direct Ownership of Biogen Inc. (BIIB)
This section provides a comprehensive overview of the insiders with direct ownership of Biogen Inc. (BIIB). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
BIOGEN INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Michel Vounatsos
Chief Executive Officer |
61,233 | 25,785 | 67,261 $8.95 Million | 9 |
Feb 18, 2022
Reduced 3.92%
|
|
Susan H Alexander
EVP Chief Legal Officer |
43,643 | 43,950 | 36,265 $4.83 Million | 26 |
Feb 10, 2025
Reduced 2.18%
|
|
Caroline Dorsa
Director |
9,905 | 0 | 31,002 $4.13 Million | 6 |
Jun 17, 2025
Added 9.25%
|
|
Michael R Mcdonnell
EVP, Chief Financial Officer |
43,954 | 19,613 | 24,341 $3.24 Million | 22 |
Feb 10, 2025
Reduced 5.33%
|
|
Eric K Rowinsky
Director |
7,270 | 0 | 24,339 $3.24 Million | 6 |
Jun 17, 2025
Added 8.87%
|
|
Ginger Gregory
EVP, Human Resources |
34,107 | 21,584 | 17,598 $2.34 Million | 25 |
Feb 10, 2025
Reduced 3.48%
|
|
Alexander J Denner
Director |
2,145 | 0 | 15,099 $2.01 Million | 2 |
Jun 15, 2022
Added 8.32%
|
|
Richard Mulligan
Director |
2,145 | 0 | 15,099 $2.01 Million | 2 |
Jun 15, 2022
Added 8.32%
|
|
Nicole Murphy
Head of Pharm Ops and Tech |
18,941 | 6,399 | 14,055 $1.87 Million | 29 |
Feb 10, 2025
Reduced 4.55%
|
|
Nancy Leaming
Director |
775 | 0 | 13,763 $1.83 Million | 1 |
Jul 01, 2021
Added 5.33%
|
|
Stephen A Sherwin
Director |
6,815 | 8,760 | 13,688 $1.82 Million | 6 |
Jun 17, 2025
Added 14.76%
|
|
Christopher Viehbacher
President and CEO |
9,008 | 3,201 | 12,807 $1.7 Million | 2 |
Feb 07, 2025
Reduced 20.0%
|
|
Alfred Sandrock
Head of Research & Development |
8,182 | 12,682 | 10,169 $1.35 Million | 5 |
Jun 07, 2021
Reduced 43.0%
|
|
Stelios Papadopoulos
Director |
3,530 | 0 | 10,095 $1.34 Million | 2 |
Jun 15, 2022
Added 18.26%
|
|
Jesus B Mantas
Director |
7,713 | 0 | 9,758 $1.3 Million | 6 |
Jun 17, 2025
Added 19.54%
|
|
William A Hawkins
Director |
6,815 | 0 | 8,860 $1.18 Million | 5 |
Jun 17, 2025
Added 21.1%
|
|
Brian S Posner
Director |
775 | 360 | 8,175 $1.09 Million | 2 |
Jul 01, 2021
Added 8.66%
|
|
Robin Kramer
Chief Accounting Officer |
11,219 | 3,734 | 8,011 $1.07 Million | 38 |
Feb 10, 2025
Reduced 2.97%
|
|
Chirfi Guindo
Head of Glob Prod Strat & Com |
11,303 | 7,810 | 7,364 $980,222 | 10 |
Feb 18, 2022
Reduced 10.66%
|
|
Maria C Freire
Director |
6,815 | 0 | 6,815 $907,144 | 5 |
Jun 17, 2025
Added 25.8%
|
|
Rachid Izzar
Head of Global Product Strat. |
19,487 | 9,159 | 6,330 $842,586 | 28 |
Jul 08, 2025
Reduced 25.99%
|
|
Priya Singhal
Head of Development |
17,098 | 13,552 | 5,427 $722,387 | 41 |
May 19, 2025
Reduced 41.22%
|
|
Susan Langer
Director |
4,670 | 0 | 5,129 $682,721 | 3 |
Jun 17, 2025
Added 31.6%
|
|
Alphonse Galdes
EVP Pharmaceutical Oper & Tech |
3,049 | 715 | 5,064 $674,069 | 4 |
Jan 19, 2022
Added 11.5%
|
|
Monish D Patolawala
Director |
3,710 | 0 | 3,710 $493,838 | 2 |
Jun 17, 2025
Added 38.98%
|
|
Adam Keeney
Head of Corporate Development |
3,677 | 1,293 | 2,384 $317,334 | 6 |
May 01, 2025
Reduced 16.0%
|
|
Lloyd Minor
Director |
2,370 | 0 | 2,370 $315,470 | 1 |
Jun 17, 2025
Added 50.0%
|
|
William D /Ca/ Jones
Director |
2,145 | 0 | 2,145 $285,520 | 2 |
Jun 15, 2022
Added 38.98%
|
|
Jane Grogan
Head of Research |
2,080 | 647 | 1,433 $190,746 | 4 |
Feb 07, 2025
Reduced 23.61%
|